Glycomar is a marine biotechnology company discovering and developing novel therapeutic molecules predominantly from the marine environment. 

Discoveries are taken through early stage development with applications in pharmaceutical, cosmetic and nutraceutical markets.

Watch Managing Director Dr Charlie Bavington discuss market opportunities in this clip from the BioMarine TV panel session.  Also on the panel is Joanne Pitt, the Knowledge Exchange Manager from the Scottish Association for Marine Science.

Highlands and Islands Enterprise with Scottish Development International, provided support to a delegation from the European Marine Science Park cluster to attend and fully participate in BioMarine 2014, held in Cascais, Portugal.

By being located in the European Centre for Marine Biotechnology, Glycomar has accessed a range of support from Highlands and Islands Enterprise to support business growth. One notable opportunity that arose for Dr Bavington was being selected to participate in the Entrepreneurship Development Programme, at the Massachusetts Institute of Technology (MIT).

This programme is a week long, high level, intensive executive education course teaching skills for high impact entrepreneurship. Held onsite at MIT, the course is aimed at highly ambitious entrepreneurs from businesses with international potential who want to learn from the best and be the best.

Listen first-hand to Charlie Bavington's experience at MIT.